Abstract
1. In dogs anaesthetized with pentobarbitone sodium, bradycardia with hypotension occurred on intracerebroventricular (i.c.v.) injection of noradrenaline (50-200 μg) or phenylephrine (100-400 μg), but tachycardia with hypotension occurred on i.c.v. injection of isoprenaline (100-200 μg).
2. These cardiovascular responses were central effects, and from the results obtained after bilateral vagotomy, removal of both stellate ganglia and transection of the upper cervical cord, it was evident that the efferent nervous pathway for all these effects was the sympathetic nervous system.
3. An i.c.v. injection of the α-adrenoceptor blocking agent phenoxybenzamine (10 mg) blocked the bradycardia and hypotension produced by noradrenaline or phenylephrine, and an i.c.v. injection of a β-adrenoceptor blocking agent, either propranolol (2 mg) or N-isopropyl-p-nitrophenyl-ethanolamine (INPEA) (10 mg), blocked the tachycardia and hypotension produced by isoprenaline.
4. The cardiovascular effects produced by i.c.v. injection of the three sympathomimetic amines could be reproduced in cross-circulation experiments in the recipient dog when the amines were injected into its head circulation, and the effects of noradrenaline and phenylephrine, but not those of isoprenaline, were abolished by the α-adrenoceptor blocking agent yohimbine (1 mg/kg) injected intravenously into the donor dog.
5. It is concluded that the central α-adrenoceptors are concerned with bradycardia and the central β-adrenoceptors with tachycardia, but that both receptors are concerned with hypotension.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BHARGAVA K. P., TANGRI K. K. The central vasomotor effects of 5-hydroxytryptamie. Br J Pharmacol Chemother. 1959 Dec;14:411–414. doi: 10.1111/j.1476-5381.1959.tb00943.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bhargava K. P., Jaju B. P., Tangri K. K. Mechanism of the central hypotensive action of guanethidine. Br J Pharmacol Chemother. 1966 Sep;27(3):491–496. doi: 10.1111/j.1476-5381.1966.tb01861.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bhargava K. P., Kohli R. P., Sinha J. N., Tayal G. Role of catecholamines in centrogenic cardiac arrhythmia induced by aconitine. Br J Pharmacol. 1969 Jun;36(2):240–252. doi: 10.1111/j.1476-5381.1969.tb09501.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bhargava K. P., Srivastava R. K. Analysis of the central receptors concerned in the cardiovascular response induced by intracerebroventricular aconitine. Neuropharmacology. 1972 Jan;11(1):123–135. doi: 10.1016/0028-3908(72)90063-9. [DOI] [PubMed] [Google Scholar]
- GOLDSTEIN L., MUNOZ C. Influence of adrenergic stimulant and blocking drugs on cerebral electrical activity in curarized animals. J Pharmacol Exp Ther. 1961 Jun;132:345–353. [PubMed] [Google Scholar]
- Gagnon D. J., Melville K. I. Centrally mediated cardiovascular responses to isoprenaline. Int J Neuropharmacol. 1967 Jul;6(4):245–251. doi: 10.1016/0028-3908(67)90012-3. [DOI] [PubMed] [Google Scholar]
- Gagnon D. J., Melville K. I. Further observations on the possible role of noradrenaline in centrally mediated cardiovascular responses. Rev Can Biol. 1966 Jun;25(2):99–105. [PubMed] [Google Scholar]
- Gupta K. P., Bhargava K. P. Mechanism of tachycardia induced by intracerebroventricular injection of hydrallazine (1-hydrazinophthalazine). Arch Int Pharmacodyn Ther. 1965 May;155(1):84–89. [PubMed] [Google Scholar]
- KANEKO Y., MCCUBBIN J. W., PAGE I. H. Mechanism by which serotonin, norepinephrine and reserpine cause central vasomotor inhibition. Circ Res. 1960 Nov;8:1228–1234. doi: 10.1161/01.res.8.6.1228. [DOI] [PubMed] [Google Scholar]
- MCCUBBIN J. W., KANEKO Y., PAGE I. H. Ability of serotonin and norepinephrine to mimic the central effects of reserpine on vasomotor activity. Circ Res. 1960 Jul;8:849–858. doi: 10.1161/01.res.8.4.849. [DOI] [PubMed] [Google Scholar]
- NASHOLD B. S., Jr, MANNARINO E., WUNDERLICH M. Pressor-depressor blood pressure responses in the cat after intraventricular injection of drugs. Nature. 1962 Mar 31;193:1297–1298. doi: 10.1038/1931297a0. [DOI] [PubMed] [Google Scholar]
- SHARE N. N., MELVILLE K. I. Centrally mediated sympathetic cardiovascular responses induced by intraventricular norepinephrine. J Pharmacol Exp Ther. 1963 Jul;141:15–21. [PubMed] [Google Scholar]
- SHARE N. N., MELVILLE K. I. INTRAVENTRICULAR INJECTIONS OF PICROTOXIN FOLLOWING CENTRAL ADRENERGIC BLOCKADE WITH PHENOXYBENZAMINE AND DICHLOROISOPROTERENOL. Int J Neuropharmacol. 1965 May;4:149–156. doi: 10.1016/0028-3908(65)90004-3. [DOI] [PubMed] [Google Scholar]
- SHARE N. N., MELVILLE K. I. INVOLVEMENT OF BRAIN STEM NOREPINEPHRINE IN PICROTOXIN AND TYRAMINE-INDUCED CENTRAL SYMPATHETIC STIMULATION. Arch Int Pharmacodyn Ther. 1965 Feb;153:267–282. [PubMed] [Google Scholar]
- Schmitt H., Fenard S. Evidence for an alpha-sympathomimetic component in the effects of catapresan on vasomotor centres: antagonism by piperoxane. Eur J Pharmacol. 1971;14(1):98–100. doi: 10.1016/0014-2999(71)90130-0. [DOI] [PubMed] [Google Scholar]
- TAYLOR R. D., PAGE I. H. Peripheral vasomotor effects of adrenaline and noradrenaline acting upon the isolated perfused central nervous system. Circulation. 1951 Oct;4(4):563–565. doi: 10.1161/01.cir.4.4.563. [DOI] [PubMed] [Google Scholar]
- UDENFRIEND S., CREVELING C. R. Localization of dopamine-beta-oxidase in brain. J Neurochem. 1959 Oct;4:350–352. doi: 10.1111/j.1471-4159.1959.tb13216.x. [DOI] [PubMed] [Google Scholar]
- VOGT M. The concentration of sympathin in different parts of the central nervous system under normal conditions and after the administration of drugs. J Physiol. 1954 Mar 29;123(3):451–481. doi: 10.1113/jphysiol.1954.sp005064. [DOI] [PMC free article] [PubMed] [Google Scholar]
- WEINER N. The distribution of monoamie oxidae and succinic oxidase in brain. J Neurochem. 1960 Aug;6:79–86. doi: 10.1111/j.1471-4159.1960.tb13451.x. [DOI] [PubMed] [Google Scholar]